Overall CVD disease burden in DALYs attributable to 1^st-level risk factors in Chile. DALYs rates are expressed per 100,000 individuals, with a 95% uncertainty interval. by Camilo Briones-Valdivieso (21567535)

Subjects:

Absolute and relative atrial fibrillation and flutter DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Overall cardiovascular disease DALYs age-standardised rate over time 1990-2021 in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Absolute and relative hypertensive heart disease DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Absolute and relative aortic aneurysm DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Absolute and relative overall CVD DALYs rate attributable to 1^st-level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Absolute and relative lower extremity peripheral arterial disease DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Percentage distribution of DALYs for cardiovascular diseases in 2021 in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Table 1_A novel α-conotoxin [D1G, ΔQ14] LvIC decreased mouse locomotor activity.xls by Wen Wang (6570)

“…</p>Conclusion<p>Our findings indicate that α-conotoxin [D1G, ΔQ14] LvIC significantly decreased locomotor activity in mice. Additionally, it altered gene expression primarily in areas related to neuronal development, synapse formation, and neuron activity, while also reducing synapse strength. …”

Table 2_A novel α-conotoxin [D1G, ΔQ14] LvIC decreased mouse locomotor activity.xls by Wen Wang (6570)

“…</p>Conclusion<p>Our findings indicate that α-conotoxin [D1G, ΔQ14] LvIC significantly decreased locomotor activity in mice. Additionally, it altered gene expression primarily in areas related to neuronal development, synapse formation, and neuron activity, while also reducing synapse strength. …”

Graded association between pack-year groups in former and current smokers and cardiovascular and mortality outcomes. by Erfan Tasdighi (9144667)

Subjects:

Original data2. by Lan Zeng (638254)

Subjects:

Overexpressing <i>RP11-502I4.3</i> inhibited the trend of angiogenesis in human retinal microvascular endothelial cells (HRMECs). by Lan Zeng (638254)

Subjects:

Original data1. by Lan Zeng (638254)

Subjects:

Establishment of overexpressing <i>RP11-502I4.3</i> model in rats. by Lan Zeng (638254)

Subjects:

Drug use proportions in Japan and Tsunan hospital across different years. by Shinichiro Ishikawa (22493274)

Subjects:

Detection of changes in <i>vascular endothelial growth factor</i> (<i>VEGF</i>) and <i>RP11-502I4.3</i> expression levels. by Lan Zeng (638254)

Subjects:

Establishment of overexpressing <i>RP11-502I4.3</i> model in human retinal microvascular endothelial cells (HRMECs). by Lan Zeng (638254)

Subjects:

Expression levels of <i>RP11-502I4.3</i> in the human vitreous humor (VH) of patients with proliferative diabetic retinopathy (PDR). by Lan Zeng (638254)

Subjects:

Trends in SMRs (95% confidence interval) for all deaths, malignant neoplasms, heart disease (ICD-10: I20–I52), and cerebrovascular disease. by Shinichiro Ishikawa (22493274)

Subjects: